BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/10/2022 5:40:20 AM | Browse: 363 | Download: 1221
 |
Received |
|
2021-08-03 19:43 |
|
Peer-Review Started |
|
2021-08-03 19:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-10-02 16:43 |
|
Revised |
|
2021-10-31 23:00 |
|
Second Decision |
|
2022-05-16 03:11 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-05-17 02:12 |
|
Articles in Press |
|
2022-05-17 02:12 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-05-26 08:26 |
|
Publish the Manuscript Online |
|
2022-06-10 05:40 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jian-Feng Gao, Yu Pan, Xian-Chao Lin, Feng-Chun Lu, Ding-Shen Qiu, Jun-Jun Liu and He-Guang Huang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Medical Centre of Minimally Invasive Technology of Fujian Province |
2017[171] |
| Joint Funds for the Innovation of Science and Technology, Fujian Province |
2017Y9059 |
| The United Fujian Provincial Health and Education Project for Tackling the Key Research |
2019-WJ-07 |
| The Medical Centre of Minimally Invasive Technology of Fujian Province |
2017[4] |
|
| Corresponding Author |
He-Guang Huang, MD, Chief Physician, Department of General Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, Fujian Province, China. heguanghuang22@163.com |
| Key Words |
Pancreatic cancer; Computed tomography; Diagnostic imaging; Kaplan-Meier curve; Prognosis; Survival analysis |
| Core Tip |
Computed tomography (CT) plays an important role in the diagnosis, staging and treatment of pancreatic tumours. Pancreatic cancer generally shows a low enhancement pattern compared with normal pancreatic tissue. In our analysis, the prognosis of patients with the tumour relative enhancement ratio (TRER) less than or equal to 0.7 was significantly worse than that of patients with TRER greater than 0.7. TRER was significantly correlated with American Joint Committee on Cancer stage, tumour stage, and lymph node stage. Preoperative enhanced CT provides a simple and effective prediction of postoperative overall survival in pancreatic ductal adenocarcinoma. |
| Publish Date |
2022-06-10 05:40 |
| Citation |
Gao JF, Pan Y, Lin XC, Lu FC, Qiu DS, Liu JJ, Huang HG. Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer. World J Gastroenterol 2022; 28(22): 2468-2481 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i22/2468.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i22.2468 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
